Papillary Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Papillary Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. [Phase 2, Phase 3]
Phase 2/3 DETERMINE trial treatment arm 05 is evaluating the combination of vemurafenib and cobimetinib in adults with BRAF-positive cancers…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening
This completed trial evaluates a robotic bilateral axillo-breast approach for relatively low-risk papillary thyroid carcinoma with lateral c…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating selpercatinib given before surgery for RET-altered thyroid cancers is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Active Surveillance of Papillary Thyroid Microcarcinoma [NA]
This clinical trial update indicates an actively recruiting study on active surveillance for papillary thyroid microcarcinoma sponsored by C…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated
A completed clinical trial update suggests that more than half of patients with unifocal cN0 T1b or small T2 papillary thyroid carcinoma may…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma [NA]
The study evaluating microwave ablation in combination with surgical resection for papillary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma
A completed clinical trial from Seoul National University Hospital reports on intraoperative pathologic evaluation of central lymph nodes in…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level
This clinical trial update evaluates the diagnostic accuracy of Fluorodeoxyglucose-18 positron emission tomography (FDG-PET) for detecting r…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma [NA]
Clinical trial update: A study on hybrid endoscopic hemithyroidectomy with targeted ablation for bilateral papillary thyroid carcinoma is cu…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer
A clinical trial update for the RET-US study investigating ultrasound-based prediction of RET alterations and lateral-neck metastasis in pap…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. [Phase 1]
A Phase 1 study intended to restore radioiodine sensitivity in advanced papillary thyroid carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update indicating that XL092 for locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study results show activity and safety of pralsetinib in RET-altered cancers, including non-small cell lung cancer and thyroid can…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation [NA]
A completed clinical trial evaluated radiofrequency ablation as a treatment for papillary thyroid carcinoma, with results posted.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
A clinical trial from Fujian Medical University is evaluating whether intraoperative neuromuscular monitoring affects acoustic outcomes befo…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients. [NA]
Clinical trial update examining the necessity of TSH suppression therapy in active surveillance for thyroid cancer, including papillary thyr…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Active Surveillance for Low-risk Papillary Thyroid Carcinoma
The National Cancer Center Korea is conducting a clinical trial to evaluate active surveillance for low-risk papillary thyroid carcinoma, an…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer [NA]
A clinical trial is assessing shared decision-making to guide treatment choices for low-risk thyroid cancer (papillary thyroid carcinoma). T…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"
This clinical trial update from Assiut University investigates cytomorphometry and BRAFV600E immunocytochemistry in cytology samples labeled…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule [NA]
The clinical trial NCT05003856 evaluating radiofrequency ablation for benign or low-risk thyroid nodules was terminated; no results are prov…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]
Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 Cm Papillary Thyroid Carcinoma [NA]
This clinical trial evaluates the role of prophylactic central compartment neck dissection in the management of 2- to 4-cm papillary thyroid…